AU4649189A - Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents - Google Patents
Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agentsInfo
- Publication number
- AU4649189A AU4649189A AU46491/89A AU4649189A AU4649189A AU 4649189 A AU4649189 A AU 4649189A AU 46491/89 A AU46491/89 A AU 46491/89A AU 4649189 A AU4649189 A AU 4649189A AU 4649189 A AU4649189 A AU 4649189A
- Authority
- AU
- Australia
- Prior art keywords
- indole
- obesity
- diabetic
- alpha
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US270554 | 1981-06-04 | ||
| US27055488A | 1988-11-14 | 1988-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4649189A true AU4649189A (en) | 1990-06-12 |
Family
ID=23031777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU46491/89A Abandoned AU4649189A (en) | 1988-11-14 | 1989-10-27 | Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPH04501722A (en) |
| KR (1) | KR920701152A (en) |
| AU (1) | AU4649189A (en) |
| CA (1) | CA2002415A1 (en) |
| IL (1) | IL92294A0 (en) |
| WO (1) | WO1990005721A1 (en) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0593513B1 (en) * | 1991-06-21 | 1998-10-28 | Smithkline Beecham Plc | Tryptamine analogues, their synthesis and their use as 5-ht1-like receptors or 5-ht2 receptor agonistes |
| US5158969A (en) * | 1991-08-21 | 1992-10-27 | Neurosearch A/S | Indole derivatives as potassium channel blockers |
| GB9523999D0 (en) | 1995-11-23 | 1996-01-24 | Lilly Co Eli | Indolyl neuropeptide y receptor antagonists |
| US5849764A (en) * | 1995-12-14 | 1998-12-15 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US5780437A (en) * | 1995-12-14 | 1998-07-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6200957B1 (en) | 1995-12-14 | 2001-03-13 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| AU707277B2 (en) | 1995-12-14 | 1999-07-08 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US5756507A (en) * | 1995-12-14 | 1998-05-26 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| JP2001511767A (en) * | 1996-12-23 | 2001-08-14 | メルク エンド カンパニー インコーポレーテッド | Diabetes medicine |
| US6156767A (en) * | 1997-06-05 | 2000-12-05 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US5985901A (en) * | 1997-06-05 | 1999-11-16 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6156772A (en) * | 1997-06-05 | 2000-12-05 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6004984A (en) * | 1997-06-05 | 1999-12-21 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US5981550A (en) * | 1997-06-05 | 1999-11-09 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6159975A (en) * | 1998-02-11 | 2000-12-12 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6077847A (en) * | 1998-04-02 | 2000-06-20 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US5985892A (en) * | 1998-04-02 | 1999-11-16 | Merck & Co., Ltd. | Antagonists of gonadotropin releasing hormone |
| US5998432A (en) * | 1998-04-02 | 1999-12-07 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6110931A (en) * | 1998-04-02 | 2000-08-29 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6228867B1 (en) | 1998-04-02 | 2001-05-08 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6025366A (en) * | 1998-04-02 | 2000-02-15 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| EP1165075A4 (en) | 1999-03-10 | 2002-04-10 | Merck & Co Inc | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| EP1171135A4 (en) | 1999-03-10 | 2002-05-15 | Merck & Co Inc | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| AU3868800A (en) | 1999-03-10 | 2000-09-28 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| IL130169A (en) * | 1999-05-27 | 2006-08-20 | Neurim Pharma 1991 | Derivatives of indole, and pharmaceutical, skin-protective and cosmetic compositions containing them |
| PE20010580A1 (en) * | 1999-09-03 | 2001-05-25 | Takeda Chemical Industries Ltd | PHARMACEUTICAL COMPOSITION TO TREAT DIABETES |
| JP2004513076A (en) | 2000-07-25 | 2004-04-30 | メルク エンド カムパニー インコーポレーテッド | N-substituted indoles useful in the treatment of diabetes |
| US6620824B2 (en) | 2001-04-11 | 2003-09-16 | Merck & Co., Inc. | Process for the synthesis of gonadotropin releasing hormone antagonists |
| WO2005044261A1 (en) * | 2003-10-27 | 2005-05-19 | University Of Iowa Research Foundation | Melatonin analogue prodrugs |
| WO2005065050A2 (en) * | 2003-12-25 | 2005-07-21 | Asahi Kasei Pharma Corporation | Bicyclic compound |
| WO2006047032A2 (en) | 2004-09-27 | 2006-05-04 | Organix, Inc. | Indole compounds useful as serotonin selective agents |
| KR100807718B1 (en) * | 2006-10-17 | 2008-02-28 | 한국생명공학연구원 | Pharmaceutical composition for the prevention and treatment of metabolic disorder containing indole derivatives as an active ingredient |
| DE102008030207A1 (en) | 2008-06-25 | 2009-12-31 | Bayer Schering Pharma Aktiengesellschaft | Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl-indoles and their use |
| DE102008030206A1 (en) | 2008-06-25 | 2009-12-31 | Bayer Schering Pharma Aktiengesellschaft | 3-cyanoalky- and 3-hydroxyalkyl-indoles and their use |
| WO2011019738A1 (en) | 2009-08-10 | 2011-02-17 | Galenea Corporation | Compounds and methods of use thereof |
| GB201411239D0 (en) * | 2014-06-25 | 2014-08-06 | Takeda Pharmaceutical | Novel compounds |
| CN114601825B (en) * | 2022-02-18 | 2023-08-04 | 复旦大学附属中山医院 | Application of intestinal flora metabolite indole-3-formaldehyde in preventing and treating atherosclerosis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2542869A (en) * | 1948-03-19 | 1951-02-20 | Merck & Co Inc | N-pyridoxyl-amino acids and process of preparing the same |
| US3074942A (en) * | 1958-01-13 | 1963-01-22 | Geigy Chem Corp | alpha-substituted glycine derivatives |
| NL125657C (en) * | 1963-11-26 | |||
| GB1080470A (en) * | 1963-12-31 | 1967-08-23 | Merck & Co Inc | Indole derivatives |
| EP0031653A1 (en) * | 1979-12-19 | 1981-07-08 | Beecham Group Plc | N-Substituted alpha-amino acids, processes for making them and pharmaceutical compositions containing them |
| LU85035A1 (en) * | 1983-10-07 | 1985-06-19 | Midit | AMIDE ACID AMIDE DERIVATIVES, PREPARATION AND USE THEREOF AS WELL AS COMPOSITIONS CONTAINING THESE DERIVATIVES |
-
1989
- 1989-10-27 JP JP2500318A patent/JPH04501722A/en active Pending
- 1989-10-27 AU AU46491/89A patent/AU4649189A/en not_active Abandoned
- 1989-10-27 WO PCT/US1989/004711 patent/WO1990005721A1/en unknown
- 1989-10-27 KR KR1019900701508A patent/KR920701152A/en not_active Application Discontinuation
- 1989-11-07 CA CA002002415A patent/CA2002415A1/en not_active Abandoned
- 1989-11-13 IL IL92294A patent/IL92294A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR920701152A (en) | 1992-08-11 |
| WO1990005721A1 (en) | 1990-05-31 |
| CA2002415A1 (en) | 1990-05-14 |
| IL92294A0 (en) | 1990-07-26 |
| JPH04501722A (en) | 1992-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4649189A (en) | Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents | |
| AU634551B2 (en) | Imidazolyl-alkenoic acids | |
| AU3793489A (en) | Imidoperoxycarboxylic acids, processes for their preparation and their use | |
| AU3079789A (en) | Amino acid derivatives | |
| AU2076692A (en) | Copolyesters, copolyamides and copolyester-amides | |
| AU4106689A (en) | Heater | |
| AU3346889A (en) | Heating element | |
| AU624436B2 (en) | Albumin preparation and process for preparing the same | |
| AU3788189A (en) | 3, 9-diphosphaspiroundecanes and process for making3, 9-diphosphaspiroundecanes | |
| AU3446189A (en) | Fatty amino acids, and homo- and hetero-oligomers and conjugates thereof | |
| AU3224489A (en) | Unsaturated N-benzopyranyllactams | |
| AU4717089A (en) | N-(3,4-Dioxy-and N-(4-oxy-3-thio-benzyl)-thioureas | |
| AU4430989A (en) | Compound, composition, process and use | |
| AU8876591A (en) | Indole-3-methanamines useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents | |
| AU3681689A (en) | C-terminus amidation enzyme composition, process for its preparation and its use | |
| AU638739B2 (en) | Substituted glutaramic acids and derivatives | |
| AU564013B2 (en) | 1,8-bridged 4-quinolone-3-carboxylic acids and derivatives | |
| AU4382189A (en) | An artwork assembly | |
| AU3305289A (en) | Concentrator | |
| AU4371389A (en) | Polyimides and process for the preparation thereof | |
| AU3255589A (en) | Amino acid derivatives | |
| AU628059B2 (en) | 8,9-annelated beta-carbolines and 8,9-annelated-3,4-dihydro- beta-carbolines | |
| AU3895589A (en) | Lead-aluminum material | |
| AU3804689A (en) | Modified proteins | |
| AU2975089A (en) | Novel compounds, process for the preparation thereof and uses thereof |